Related by context. All words. (Click for frequent words.) 65 Pharmacologic 65 Neurodegenerative 64 Novel Therapeutic 64 Neuroprotection 64 Diagnostic Criteria 64 Immunotherapeutic 63 Neurocognitive 63 Neurogenic 63 AstraZeneca Targacept 63 #:#-# [037] 63 Hippocampal 63 Cardiotoxicity 63 Molecular Basis 63 Heritability 62 Immunological 62 Cannabinoid 62 Clinical Outcome 62 Small Molecule 62 Prolongs Survival 61 Antiangiogenic 61 Subtypes 61 Genetic Markers 61 Cognitive Deficits 61 Anti Tumor 61 Clinical Trial Data 61 Nuclear Receptors 61 Ischemic 61 transgenic mouse models 61 Analytical Tool 61 Novel Oral 61 Dehydrogenase 61 Autoimmune Disease 61 Prognostic Value 61 Inflammatory Arthritis 61 Molecular Cancer 61 Mimetics 61 Thalamus 61 Neuroanatomy 61 Shows Promise Against 61 Isis Pharma 61 Dyslipidemia 61 Molecular Mechanism 61 Nicotine Vaccine 61 Schizophrenia Treatment 61 Pathogenesis 61 #:#-# [001] 61 Refractory Angina 61 Tumor Angiogenesis 61 Crit Rev 61 Motility 61 Anticancer Agents 61 Hepatic Encephalopathy 60 Kinase Inhibitors 60 Diastolic Heart Failure 60 See CLINICAL PHARMACOLOGY 60 Crystallographic 60 Oncogene 60 Anticancer Drug 60 Trandolapril 60 Metabolic Disease 60 #:#-#,# CrossRef Medline [002] 60 Tumor Microenvironment 60 J Nutr 60 Differential Diagnosis 60 #-# Full Text 60 Mouse Models 60 Arch Neurol 60 Novel Therapies 60 Tyrosine Kinase Inhibitor 60 Progenitor Cell 60 Metabolic Disorder 60 Lipid Metabolism 60 Comorbidity 60 Breast Cancer Metastasis 60 Diabetic Foot Ulcer 60 Peripheral Arterial 60 Treatment Algorithms 60 Schizoaffective Disorder 60 #:#-# [006] 60 Modulates 60 Antigen Specific 60 Extracellular Matrix 60 Cell Signaling 60 Psychiatric Diagnosis 60 Systemic Delivery 60 BiolineRX 60 Systemic Sclerosis 59 Iloperidone 59 Thrombotic 59 #:#-# [033] 59 Effective Treatments 59 Thymosin Beta 4 59 Targeted Therapeutics 59 Autoimmune Disorders 59 beta 1a 59 Growth Hormone Deficiency 59 RNA Interference 59 Lung Cancer Drug 59 Bipolar Mania 59 J Clin 59 Predisposition 59 Neurotherapeutics 59 Dendritic Cells 59 Cytometry 59 Inhibitory 59 miRagen Therapeutics 59 Biomarker Study 59 Diabetic Nephropathy 59 Postdoctoral Position 59 Aptamer 59 Risk Stratification 59 Cell Adhesion 59 Biotechnol 59 Replacement Therapy 59 Genetic Marker 59 Intervention Effectiveness CATIE 59 Successfully Completes Phase 59 Cancer Vaccines 59 Immunostimulatory 59 Genetic Variation 59 Urologic Cancer 59 Cytotoxic 59 Preclinical Study 59 Fibroblast 59 Treating Chronic 59 Licenses Novel 59 Novel Therapeutics 59 Drug Shows Promise 59 Hematological 59 Phase 2a Trial 59 Nucleic Acids 59 Bipolar Disorders 59 Nonclinical 59 Protein Expression 59 Neuropharmacology 59 HDAC Inhibitor 59 Pharmacogenetic 59 Research www. elsevier.com 59 Pharmacological 59 Novel Inhibitor 59 SYN X 59 Molecular Mechanisms 59 Lentiviral 59 #:#-# [023] 59 Neurochemistry 59 PF # [002] 59 Suicidality 59 Neuroprotective 59 Physiology Seminar 59 Rheumatoid Arthritis Drug 59 Conjugated 59 Inflammatory Disease 59 Bioequivalence 59 Glycosylation 58 Antiviral Therapy 58 Circulatory Support 58 Oligonucleotides 58 Chemoprevention 58 PDE inhibitors 58 Angiotensin Converting Enzyme 58 Metabolic Endocrinology 58 Mutagenesis 58 Prostate Disease 58 Atopic Dermatitis 58 Genes Involved 58 Islet Transplantation 58 Benign Prostatic Hyperplasia 58 Gastric Cancer 58 Myelodysplastic Syndrome MDS 58 Diabetic Neuropathy 58 Monoclonal 58 Safinamide 58 Int J 58 Transcriptome 58 transcranial Doppler ultrasound 58 Amino acid 58 neurokinin 1 58 Mouse Model 58 Adult Stem Cell Therapy 58 Prospective Randomized 58 #:#-# [025] 58 Gene Silencing 58 CNS Disorders 58 Neuronal 58 Alexza Pharma 58 neuropsychiatric diseases 58 Therapeutic Antibody 58 Immunologic 58 Cytochrome P# 58 Antibody Discovery 58 Initiates Clinical Trial 58 Cenomed 58 Myoblast 58 Neurodegenerative Disease 58 Initiates Clinical 58 Comorbidities 58 Clinical Proteomics 58 Antipsychotic Drug 58 Clinical Significance 58 Protein Biomarker 58 Neoplasms 58 Treat Parkinson Disease 58 endophenotypes 58 GW# [003] 58 MEVACOR 58 Lupus Drug 58 vitro pharmacology 58 HDL Selective Delipidation 58 Proteasome 58 Shire plc SHPGY 58 Transdermal Delivery 58 Completes Patient Enrollment 58 Chemokine 58 Neurol 58 Immune Therapy 58 Acute Liver Failure 58 Liver Injury 58 Hematopoietic Stem Cells 58 Anavex #-# 58 Biophysical 58 Lp PLA 2 58 Kahalalide F 58 Protease Inhibitors 58 Pharmacodynamic 58 Bone Metastases 58 Quark Pharmaceuticals 58 Adrenomyeloneuropathy AMN 58 Anticancer Agent 57 Unstable Angina 57 Recombinant Human 57 Cancer Stem Cells 57 Neurogenesis 57 Tesmilifene 57 X Chromosome 57 Therapeutic Competitors Report 57 Brain Stimulation 57 Teriflunomide 57 Functional neuroimaging 57 Takeda Pharma 57 Parkinson Disease PD 57 Muscle Wasting 57 #:#-# [003] 57 Monoclonal Antibodies 57 Postmenopausal hormone therapy 57 Protein Kinase 57 Homeostasis 57 neuropathologic 57 Childhood Trauma 57 Milestone Payment 57 Alexion Soliris 57 Cognitive Disorders 57 RhuDex 57 Phenotypic 57 Degarelix 57 Biomolecules 57 Conatus Pharmaceuticals 57 Adverse Event 57 Neurobiological Technologies 57 Analytical Biochemistry 57 Antipsychotic 57 Psychiatric Illness 57 Epithelium 57 cathepsin K inhibitor 57 #:#-# [007] 57 Am J Geriatr 57 Ziprasidone 57 Orqis Medical 57 CardioVascular BioTherapeutics 57 Kinase Inhibitor 57 sitaxsentan 57 Prognostic Factors 57 Cancer Res 57 Contrast Agent 57 Treating Depression 57 Gene Linked 57 Oncology Compounds 57 Eye Diseases 57 Endocrinol 57 Cell Differentiation 57 #:#-#,# [003] 57 Neurodegeneration 57 Drug Metabolism 57 Preclinical Models 57 Bioorganic 57 Cerebral Cortex 57 Aurora Kinase 57 Phase IIA 57 EGIR 57 Treatment Algorithm 57 Cardiovasc 57 Structure Function 57 Shows Efficacy 57 Seroquel quetiapine 57 Deforolimus 57 Nat Genet 57 Protein Linked 57 Chronic Renal Failure 57 Squalamine 57 FDA CDER 57 Ocrelizumab 57 Frontotemporal Dementia 57 Technosphere ® 57 Brain Wiring 57 Carotid Artery Stenting 57 Vernakalant 57 Biobehavioral 57 Multiple Ascending Dose 57 Immunol 57 Neurotoxicity 57 Myocardial Ischemia 57 Sapacitabine 57 Hypercholesterolemia 57 Valdoxan 57 Single Molecule 57 Cell Signalling 57 Oligonucleotide 57 Clinical Trial Results 57 Migraine Drug 57 PHRM 57 J Appl 57 ILLUSTRATE 57 Therapeutic Targets 57 Nicotinic 57 Files IND 57 Silodosin 57 Bioavailability 57 J Neurosurg 57 Preclinical Data 57 Pancreas Cancer 57 J Consult Clin 56 Laryngeal Cancer 56 Fumapharm 56 Velcade bortezomib 56 mediated inhibition 56 Nerve Growth 56 Genetic Mutation 56 Lamotrigine 56 Intervention Effectiveness 56 Pharmacother 56 Heterogeneity 56 Prenatal Diagnosis 56 PI3K/mTOR 56 Antisense 56 Psychodynamic 56 Ercole Biotech 56 Glial 56 OSI Pharma 56 Oncol 56 Vertebral Fractures 56 Inflammatory Response 56 protein misfolding diseases 56 Cardiac Rhythm 56 Gene Variants 56 Sustained Release 56 Investigational Treatment 56 Ltd Therapeutic Competitors 56 Genetic Therapy 56 Targeted Therapy 56 Curr Opin 56 Angiogenic 56 Magnetic Stimulation 56 Mitochondrial Dysfunction 56 Announce Collaboration Agreement 56 J Cardiovasc 56 SLITRK1 56 PRIALT 56 Protein Interactions 56 Valsartan 56 Mol Cell 56 pathophysiological mechanisms 56 Mechanistic 56 Electrophysiological 56 Microstructure 56 Bioartificial Liver 56 Therapy Improves 56 Glypromate 56 Breast Tissue 56 Pulmonary Arterial Hypertension 56 Insulin Resistance 56 midstage clinical 56 Neurological Diseases 56 NPS Pharma 56 Investigator Initiated 56 Myelodysplastic Syndromes 56 Neuroprotective Effects 56 Disord 56 mGluR2 NAM 56 Initiates Phase III 56 Allon Therapeutics 56 Supernus Pharmaceuticals 56 Electroencephalography 56 Chemotherapeutic Agents 56 MassGeneral Institute 56 Contrast Agents 56 Tyrosine Kinase Inhibitors 56 Drug Fails 56 Retrovirus 56 Dendrimer 56 schizophrenia CIAS 56 Almorexant 56 Locus Pharmaceuticals 56 Factor VIIa 56 Alnylam ALNY 56 Ischaemic 56 Azacitidine 56 Scripps Genomic Medicine 56 proteasome inhibition 56 Reproductive Toxicology 56 Estrogen Receptor 56 Prostate Cancer Vaccine 56 Hyperlipidemia 56 Protein Synthesis 56 Pluripotent Stem Cells 56 Systematic Review 56 Zoloft sertraline 56 Aflibercept 56 Valve Replacement 56 treat benign prostatic 56 Biological Complexity 56 Corautus Genetics 56 Brain Tumor Therapy 56 serine protease inhibitor 56 Neural Circuits 56 DOV Pharmaceuticals 56 Neuropsychiatric 56 Antidiabetic 56 lymphoproliferative disorders 56 Serious Adverse Events 56 Pediatric Oncology Branch 56 Cognitive Dysfunction 56 Oral Fingolimod 56 Cardiac Stem Cell 56 Gamma secretase 56 Neural Stem Cells 56 BrainCells 56 Gender Differences 56 Genetic Susceptibility 56 Epilepsy Drug 56 Leukemias 56 Radiation Induced 56 Showed Significant 56 Toxicol 56 Meta Analysis 56 #:#-# [029] 56 Neurimmune 56 Lu AA# 56 VentiRx Pharmaceuticals 56 Human Gene Therapy 56 Renal Cancer 56 Protein Folding 56 #:#-# [035] 56 Aggrastat 56 Muscarinic 56 Pharmacogenetics 56 ERYtech 56 dopamine D2 56 Ischemic Stroke 56 mecamylamine 56 Mass Spectroscopy 56 STEP BD 56 Dual Antiplatelet Therapy 56 Immunochemistry 56 Hematopoietic 56 Presents Preclinical Data 56 Macromolecules 56 Onconase 56 gefitinib Iressa 56 Agios Pharmaceuticals 56 RELOVAIR ™ 56 Lipoprotein 56 #-# PMID # 56 Microvascular 56 Initiates Phase 2b 56 Taligen Therapeutics 56 Dopaminergic 56 Geriatric Cognitive Disorders 56 Inosine 56 #:#-#,# CrossRef Medline [001] 56 Genomic Analysis 56 Confirmatory Phase 56 ImmunoCellular Therapeutics 56 Irritable Bowel 56 Shc 56 Symptom Severity 56 Br J 56 Neurological Disease 56 Autoimmunity 56 Female Urology 55 Metastatic Cancer 55 Nicotine Addiction 55 Amplimmune 55 differential gene expression 55 Multiple Myeloma MM 55 Valeant Pharma 55 PDE# inhibitors 55 Histopathological 55 SUTENT ® 55 Incretin 55 TKPHF 55 Neurosurg 55 Bremelanotide 55 receptor antagonism 55 Circadian Clock 55 Hepatitis C Virus 55 Fabry Disease 55 Clinical Trial Enrollment 55 Stakeholder Opinions 55 Anticancer Activity 55 Diagnostic Tests 55 Respiratory Virus 55 Epithelial Cell 55 Vascular Dementia 55 Treatment Approaches 55 neurocognitive deficits 55 Molecular Genetic 55 Nonalcoholic Fatty Liver Disease 55 segment Biotest 55 Azilect rasagiline 55 Nocturia 55 Microwave Ablation System 55 Randomized Study 55 Alzheimer disease cognitive impairment 55 Develop Novel 55 dopamine hypothesis 55 Solubility 55 Severe Sepsis 55 Cardiovascular Pharmacology 55 Novel Protein 55 Patient Oriented 55 Toxicogenomics 55 Cell Biol 55 Prolexys 55 Systemic Lupus Erythematosus SLE 55 Antithrombin 55 Insulin Glargine 55 Often Misdiagnosed 55 Cervical Spine 55 PPID 55 Genetic Variations 55 Nereus Pharmaceuticals 55 Creabilis Therapeutics 55 periprocedural MI 55 Dilated Cardiomyopathy 55 Brainsway 55 Sycrest 55 DNA Methylation 55 Acute Coronary Syndromes ACS 55 #:#-# [031] 55 Galectin 3 55 Clinical Psychopharmacology 55 Asthma COPD 55 Lysis 55 melanocortin receptor 55 neuronal nicotinic receptor NNR 55 experimental allergic encephalomyelitis 55 Immune Mediated 55 Tumor Targeted 55 DP VPA 55 Hepatotoxicity 55 Patellofemoral 55 Cardiovascular Imaging 55 RNAi Therapeutics 55 INS# [001] 55 KRAS gene mutations 55 Therapeutic Advances 55 Generalized Anxiety Disorder 55 Endometrial Cancer 55 Liver Failure 55 Beta Blocker 55 nitric oxide donating prostaglandin 55 DNA Microarray 55 Drug Interactions 55 rxRNA 55 journal Clinical Pharmacology 55 Non Invasive Treatment 55 Behavioral Neurology 55 #:#-#,# [002] 55 phase IIIb 55 #:#-# [002] 55 Cancer Immunotherapy 55 Phase IIb Clinical Trial 55 Signal Transduction 55 Targacept NASDAQ TRGT 55 uricase 55 Gene Mutation 55 Bosentan 55 Venlafaxine 55 Polycythemia Vera 55 Optimer Pharma 55 ibudilast 55 Protein Involved 55 Suppl. 55 Angioedema 55 Microarray Analysis 55 Camptothecin 55 IND Filing 55 CCR1 55 adult mesenchymal stem 55 Transdermal Patch 55 Seattle Genetics SGEN 55 Main Outcome Measure 55 thalidomide Thalomid 55 Innate Immune 55 Arthritis Drug 55 Urogenital 55 alpha#beta# 55 Autoimmune Diseases 55 Study Shows Significant 55 Sleep Disturbances 55 Pimavanserin 55 reuptake inhibitor 55 Sunesis Pharma 55 Wellstat 55 Clusterin 55 Elucidation 55 Psychiatric Disorders 55 Population Genetics 55 Antisoma AS# 55 Myocardial Perfusion 55 Molecular Diagnostic 55 Vasculature 55 Phosphatase 55 Renal Cell Carcinoma RCC 55 Embolic Protection 55 Myocardial Perfusion Imaging 55 paroxetine sertraline 55 Geographic Atrophy 55 Overactive Bladder 55 Statistical Methods 55 mGluR 55 Subtype 55 DermTech International 55 recombinant FVIII 55 Immunomedics Announces 55 FDA Approvals 55 Low Dose 55 Parathyroid Hormone 55 Cognitive Impairment 55 Submits NDA 55 Sipuleucel T 55 Sleep Disturbance 55 Genetic Basis 55 Initiates Enrollment 55 Amyloid 55 Protein Structures 55 Receptor Antagonists 55 Transcriptional 55 CellMed 55 Insufficiency 55 NanoBio Corporation 55 Protein Structure 55 Psoriasis Drug 55 Fulvestrant 55 idiopathic Parkinson disease 55 Pathol 55 Decitabine 55 Fibrinogen 55 Allogeneic 55 Coronary Artery Calcium 55 Cathepsin S 55 Pediatr 55 MLNM 55 Biostatistical 55 Free Full Text 55 Morphological 55 Epidemiological Studies Unit 55 Glatiramer acetate 55 inverse agonist 55 #:# -# [004] 55 Genes Linked 55 Treatment Shows Promise 55 Investigational Compound 55 Assessment Questionnaire 55 Cinacalcet 55 Amorcyte 55 Therapeutic Antibodies 55 Bucindolol 55 Neuroimmunology 55 Cognitive Problems 55 Posttraumatic 55 Autoimmune 55 Hormone Replacement 55 Biogen Elan 55 Computational Genomics 55 Chronic Heart Failure 55 genetic polymorphism 55 Monoclonal antibody 55 Environ Health Perspect 55 Commercialize Novel 55 Brain Plasticity 55 Regeneron Pharma 55 Vaccine Immunology 55 Etiology 55 MGd 55 Pathophysiology 55 Polymorphism 55 Signaling Pathways 55 Cardiometabolic 55 Cytokinetics CYTK 55 ParAllele 55 Interferon beta 55 selective estrogen receptor modulator 55 Osteoporosis Drug 55 Hydra Biosciences 55 STRIDE PD 55 Biol Sci Med 55 Multicenter Phase 55 Drug Absorption 55 HLA DR4 55 Radiation Dose 55 Biomaterial 55 translational neuroscience 55 Acute Stroke 55 Carbamazepine 55 Tumor Targeting 55 TIMI Study Group 55 Val HeFT 55 Hematological Cancers 55 Echocardiographic 55 Skeletal Muscle 55 JAK Inhibitor 54 Abstract P# [002] 54 fosbretabulin 54 Clinical Decision Making 54 SNCA 54 Gets FDA Clearance 54 vascular cognitive impairment 54 A3 adenosine receptor 54 Dose Response 54 Susceptibility Testing 54 Neurovirology 54 Saegis Pharmaceuticals 54 Acute Coronary Syndromes 54 Randomized Evaluation 54 telomere dysfunction 54 Predictive Toxicology 54 Nalini Ranjit 54 metaanalysis 54 Eur J 54 Hsp# Inhibitor 54 Behavioral Genetics 54 Vaccine Adjuvants 54 metastatic malignant 54 Hemorrhagic Stroke 54 Choroidal Neovascularization 54 Interferon Alfa 54 Iron Overload 54 Salivary 54 Oral Insulin 54 Whole Genome 54 lysosomal storage disorder 54 Interferon Beta 54 Retinoic Acid 54 Epitopes 54 2A receptor agonist 54 Presents Positive 54 Teratology 54 #p# [003] 54 Clinical Antipsychotic Trials 54 Oxidative Stress 54 agomelatine 54 gastrointestinal dysfunction 54 Oncologic 54 Slow Progression 54 Plaque Psoriasis 54 Chronic Lyme Disease 54 Fibrosis 54 Upregulation 54 Severe Asthma 54 Antiarrhythmic 54 Eur Urol 54 Transcription Factor 54 Orally Active 54 Human Antibody 54 Therapeutic Protein 54 MBRX 54 Angiotensin 54 Obstet Gynecol 54 Teva Provides Update 54 Procyon Biopharma 54 myeloproliferative 54 Sygnis 54 #:#-# [024] 54 #:#-# [019] 54 J Pediatr 54 Psychosomatics 54 JACC Cardiovascular Interventions 54 Angiographic 54 Lung Injury 54 Alzheimer Disease Genetics 54 retinoid X 54 Individualized Therapy 54 Genetic Disorders 54 controlled multicenter Phase 54 Bacterial Cell 54 Subgroup analysis 54 Substance Dependence 54 Zosano Pharma 54 Anti Infectives 54 Teriparatide 54 antiapoptotic 54 Comorbid 54 Temsirolimus 54 Tofranil 54 Erythropoietic 54 Alzheimers Disease 54 neurocognitive impairment 54 Brain Scans 54 Pharmacogenomics 54 Neurophysiological 54 VIRxSYS 54 Prospective Multicenter 54 Phosphorylation 54 IV Busulfex 54 Reports Preclinical Data 54 Akathisia 54 novel immunotherapeutic 54 Vascular Ultrasound 54 platform HDL Mimetic 54 Mol Med 54 Mucosal Immunology 54 Pivotal Phase III 54 abacavir Ziagen 54 Valvular 54 hyperhomocysteinemia 54 donepezil Aricept 54 Androxal TM 54 Panic Disorder 54 Fibroblast Growth Factor 54 Chronic Constipation 54 Multicenter Trial 54 Neural Stem Cell 54 Treatment Outcome 54 SR# [004] 54 paroxysmal nocturnal hemoglobinuria 54 pathological hallmarks 54 FKBP# 54 Molecular Therapeutics 54 Thromb Haemost 54 Pharmacogenomic 54 Allergic Rhinitis 54 Biogen Idec Elan 54 Endocrine Practice 54 catechol O methyltransferase 54 Clinical Trials Consortium 54 Rheumatol 54 Social Phobia 54 Adenoscan R 54 Akebia Therapeutics 54 Febuxostat 54 constipation predominant irritable bowel 54 ChondroGene 54 ABL1 54 Cerebrovascular Diseases 54 Glucocorticoid 54 Genvec 54 JAK2 inhibitor 54 #:#-# [027] 54 levetiracetam Keppra 54 Mechoulam 54 Prostatitis 54 CRF antagonists 54 pregabalin Lyrica 54 Actelion Pharmaceuticals Ltd 54 Intervention Trial GAIT 54 Ophthotech 54 Clinical Evaluation 54 prospective multicentre 54 Septin 9 54 Dyskinesia 54 intracranial stenosis 54 Liprotamase 54 RhuDex TM 54 selective inhibition 54 Aneurysm Repair 54 Jurilab 54 Glatiramer Acetate 54 Alexion Pharma 54 Minimally Invasive Treatment 54 Asthma Intervention 54 Enzastaurin 54 ropinirole Requip 54 BMC Musculoskeletal Disorders 54 Chronic Cerebrospinal Venous Insufficiency 54 hemangioblast 54 Idera Pharmaceuticals 54 Imaging Techniques 54 Exploit collaboration 54 Psychotic Disorders 54 Radiat 54 genomewide 54 Epstein Barr Virus 54 Proteomic 54 Aposense 54 Shimadzu Scientific Instruments 54 Nitric Oxide Synthase 54 Present Preclinical Data 54 Initiates Phase II 54 Rheumatoid 54 Hepatocellular Carcinoma 54 Serdolect ® 54 Metabolomics 54 High Throughput Sequencing 54 Enzyme Replacement Therapy 54 5 HT2A 54 fibromyalgia syndrome 54 Biol 54 Cytotoxic T 54 NMR Spectroscopy 54 HeFH 54 Heartscape Technologies 54 Musculoskeletal Diseases 54 Myocardial Infarction 54 Low Incidence 54 Nanoemulsion 54 Optical Sensors 54 Anesth 54 Clinical Validation 54 Fecal Incontinence 54 Lipid Sciences 54 Psychosocial Factors 54 Oncogenic 54 PharmaVitae Profile 54 Acute Decompensated Heart Failure 54 Reduces Mortality 54 Acute Pain 54 MEMY 54 Emerging Therapies 54 Biomarker Panel 54 Optical Coherence Tomography 54 ABIO 54 immunodeficiencies 54 Interfacial 54 Trigeminal Neuralgia 54 Combunox 54 AC Immune 54 Bipolar Depression 54 Male Infertility 54 Escitalopram 54 Gastrointestinal Disease 54 calcitonin gene related 54 Single Molecule Sequencing 54 rivastigmine Exelon 54 Diasome 54 NASDAQ OMER 54 Bayer HealthCare Onyx Pharmaceuticals 54 Atomoxetine 54 biliary tract cancer 54 complement inhibitor eculizumab 54 CAMPATH 54 Immunodiagnostics 54 Neurodegenerative Disorders 54 Insulin Sensitivity 54 Genes Associated 54 Diabetic Kidney Disease 54 Acute Heart Failure 54 neuronal dysfunction 54 Phenotyping 54 Pediatric Psychopharmacology 54 Mild Cognitive Impairment 54 Percutaneous Tibial Nerve Stimulation 54 Innate Immunity 54 Leydig cell 54 Adherex Technologies 54 Tissue Repair 54 myelofibrosis polycythemia vera 54 Chronic Wounds 54 Fingolimod 54 aMCI precursor 54 Antiepileptic Drug 54 Romark Laboratories 54 YM Biosciences 54 Breast Ovarian Cancer 54 Lipodystrophy 54 PGxHealth division 54 mineralocorticoid 54 journal Nature Reviews 54 Donepezil 54 Mammalian Cells 54 Cocaine Addiction 54 Preimplantation 54 LEAD Therapeutics 54 Cancer Biomarkers 53 Disease Modification 53 Nanopore 53 vasoactive 53 Novel Antibody 53 Oral Presentation # 53 Myeloid 53 Genetic Testing 53 arterial calcification 53 Novel Mechanism 53 OvaRex R 53 #:# -# [003] 53 #beta HSD1 53 Chronic Sinusitis 53 Neuropsychological 53 extracellular dopamine 53 Neuroinflammation